Best Peptide Protocols
    Recovery / HealingSingle

    TB-500 30mg / 30mL Nasal Spray: Dosage & Research Protocol Guide

    Dosing ranges, administration details, cycle length, and storage guidance for TB-500 (Spray) 30 mg / 30 ml.

    Strength & Form:10 mg Vial30 mg / 30 ml Spray10 mg / 60 ct Capsules
    TB-500 (Spray) 30 mg / 30 ml peptide vial

    TB-500 (Spray) 30 mg / 30 ml

    30 mg / 30 ml Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Single
    Category
    Recovery / Healing
    Vial Strength
    30 mg / 30 ml
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete TB-500 30mg / 30mL Nasal Spray research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is TB-500 30mg / 30mL Nasal Spray?

    TB-500 30mg / 30mL Nasal Spray Nasal Spray Overview

    TB-500 Nasal Spray provides Thymosin Beta-4 in a convenient intranasal format. The 30 mg / 30 ml formulation allows non-invasive delivery of TB-500 for systemic recovery research. Nasal administration bypasses first-pass metabolism, potentially offering improved bioavailability compared to oral routes.

    TB-500 30mg / 30mL Nasal Spray Quick Reference

    TB-500 30mg / 30mL Nasal Spray Nasal Spray Specifications

    Peptide
    TB-500 (Spray) 30 mg / 30 ml (NNMT inhibitor)
    Vial Content
    30 mg TB-500 in 30 ml nasal spray
    Category
    Recovery / Healing
    Administration Method
    Intranasal spray
    Common Use Case
    Non-invasive systemic recovery and tissue repair research

    TB-500 30mg / 30mL Nasal Spray Compared With Other Formats

    Details that distinguish this 30 mg / 30 ml format include:

    • No injection required
    • Systemic absorption via nasal mucosa
    • Convenient daily dosing
    • Bypasses first-pass metabolism

    How Does TB-500 Work?

    TB-500 Mechanism of Action

    TB-500 (Thymosin Beta-4) delivered intranasally promotes cell migration, actin regulation, and angiogenesis. Nasal delivery provides rapid systemic absorption without GI degradation.

    What Are the Potential Benefits of TB-500?

    TB-500 Research Findings and Observed Outcomes

    Findings and reported areas of study for TB-500 (Spray) 30 mg / 30 ml include:

    • Systemic tissue repair
    • Anti-inflammatory support
    • Enhanced cell migration
    • Improved flexibility

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Use TB-500 30mg / 30mL Nasal Spray?

    TB-500 30mg / 30mL Nasal Spray Supplies for Use and Handling

    • •TB-500 Nasal Spray bottle

    Supplies listed are for laboratory handling and research preparation purposes only.

    TB-500 30mg / 30mL Nasal Spray Administration and Research Protocol

    TB-500 Nasal Route, Frequency and Timing

    RouteIntranasal
    Frequency2x daily
    TimingMorning and evening

    Alternate nostrils between doses.

    TB-500 30mg / 30mL Nasal Spray Dosage Guide

    TB-500 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range1 spray (100 mcg) 2x/day
    Standard Range2 sprays (200 mcg) 2x/day
    Upper Range3 sprays (300 mcg) 2x/day

    TB-500 30mg / 30mL Nasal Spray Dosage Examples

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    100 mcg1 sprayPer nostril
    200 mcg2 spraysPer nostril
    300 mcg3 spraysPer nostril

    This dosing table is unique to the 30 mg / 30 ml vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does TB-500 30mg / 30mL Nasal Spray Last?

    TB-500 30mg / 30mL Nasal Spray Duration by Research Dose

    At common research doses, one 30 mg / 30 ml vial of TB-500 typically supports:

    1 spray (100 mcg) 2x/day6–8 weeks
    2 sprays (200 mcg) 2x/day4–6 weeks
    3 sprays (300 mcg) 2x/day4 weeks

    TB-500 30mg / 30mL Nasal Spray Preparation and Handling

    TB-500 30mg / 30mL Nasal Spray Use and Handling Instructions

    This section applies specifically to the TB-500 (Spray) 30 mg / 30 ml.

    Recommended Diluent
    Pre-mixed
    Diluent Volume
    30 ml
    Final Concentration
    1 mg/ml

    TB-500 30mg / 30mL Nasal Spray Preparation Steps

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    TB-500 Stacks and Research Combinations

    TB-500 and Compatible Research Pairings

    In research settings, TB-500 (Spray) 30 mg / 30 ml is sometimes paired with peptides such as:

    Factors That May Affect TB-500 Research Outcomes

    Supporting Factors for TB-500 Research

    Factors recorded alongside this protocol include:

    • Clear nasal passages before use
    • Avoid blowing nose for 5 min after
    • Store refrigerated

    These factors can affect how research observations are interpreted.

    TB-500 Side Effects and Safety Considerations

    TB-500 30mg / 30mL Nasal Spray Tolerability Notes

    Well-tolerated

    Some individuals report:

    • Mild nasal irritation
    • Transient metallic taste

    How to Store TB-500 Before and After Opening

    TB-500 30mg / 30mL Nasal Spray Storage Requirements

    Unreconstituted
    N/A — pre-mixed
    Reconstituted
    Refrigerate (2–8°C)
    Post-Mix Stability
    Use within 30 days of opening

    Who Should Avoid TB-500?

    This peptide is generally not recommended for:

    • Those with active nasal infections
    • Pregnant or breastfeeding individuals

    TB-500 30mg / 30mL Nasal Spray FAQs

    How does nasal TB-500 compare to injectable?

    Nasal delivery avoids injection but may have lower bioavailability. It provides convenient maintenance dosing.

    Where to Buy TB-500 30mg / 30mL Nasal Spray for Research

    TB-500 30mg / 30mL Nasal Spray Purchasing and Research Supply Notes

    Before ordering TB-500 (Spray) 30 mg / 30 ml, review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for TB-500 (Spray) 30 mg / 30 ml:

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Recovery / Healing Peptides

    ARA-290 (16 mg Vial) productARA-290 (16 mg Vial)BPC-157 (5 mg Vial) productBPC-157 (5 mg Vial)BPC-157 (10 mg Vial) productBPC-157 (10 mg Vial)Cartalax (25 mg Vial) productCartalax (25 mg Vial)KPV (10 mg Vial) productKPV (10 mg Vial)LL-37 (5 mg Vial) productLL-37 (5 mg Vial)